5 Cambridge biotech companies to watch

These are just some of the 440 innovative life sciences companies in or around Cambridge.

by Adam Gale

Kymab 

Transgenic monoclonal antibodies
Funding: $229.4m

Sanger Institute spinout Kymab genetically engineers mice to produce human antibodies against diseases as diverse as cancer, atopic dermatitis and anaemia. Fuelled by funding from the Bill & Melinda Gates Foundation, it’s also working on promising novel vaccines against malaria and HIV.

F-Star

Bispecific antibodies
Funding:
$56m in venture capital; $200m in revenues and non-dilutive capital

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: mtsupport@haymarket.com

Call: 020 8267 8121

Register

FREE

  • Up to 4 free articles a month
  • Free email bulletins

Register Now

Become a subscriber

From £66 a quarter

  • Full access to managementtoday.co.uk
  • Exclusive event discounts
  • Management Today's print magazine
  • Plus lots more, including our State of the Industry Report.

Choose a Package